Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Function of Lipoprotein Differs in Cardiac Patients

By LabMedica International staff writers
Posted on 12 Jul 2011
The function of high-density lipoproteins (HDL) is different in patients suffering from coronary artery disease (CAD) than in healthy individuals. More...


Lipid profile blood tests indicate that high levels of "good" cholesterol (HDL cholesterol) are associated with a decreased risk of CAD, a disease of the major arterial blood vessels that is one of the major causes of heart attack and stroke.

Scientists from the University of Zurich, (Zurich, Switzerland), have investigated whether the protective potential of HDL is to be harnessed, its biological functions as well as its abundance should be considered. The investigators tested the blood from 50 patients with heart disease and 25 health individuals. They demonstrated that, in contrast to HDL from healthy subjects, HDL from patients with stable CAD or an acute coronary syndrome (HDLCAD) does not have endothelial anti-inflammatory effects and does not stimulate endothelial repair because it fails to induce endothelial nitric oxide (NO) production.

This was because in HDLCAD patients, activated endothelial lectin-like oxidized low-density lipoprotein (LDL) receptor 1 (LOX-1), triggered endothelial protein kinase isoform, (PKCβII), activation. This in turn inhibited the enzyme endothelial nitric oxide synthase (eNOS)-activating pathways and eNOS-dependent NO production. They identified reduced HDL-associated paraoxonase 1 (PON1) activity as one molecular mechanism leading to the generation of HDL with endothelial PKCβII-activating properties, at least in part due to increased formation of malondialdehyde in HDL.

The authors concluded that in patients with CAD, HDL gains endothelial LOX-1 and thereby PKCβII-activating properties due to reduced HDL-associated PON1 activity, and that this leads to inhibition of eNOS-activation and the subsequent loss of the endothelial anti-inflammatory and endothelial repair-stimulating effects of HDL. These findings support the concept that the biological functions of HDL in addition to its plasma levels may have to be taken into account to assess the cardiovascular effects of HDL-raising therapies in patients with CAD. The article was published on July 1, 2011 in the Journal of Clinical Investigation.

Related Links:
University of Zurich



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.